![Allen Goodship](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Allen Goodship
Entité | Type d'entité | Industrie | |
---|---|---|---|
Azellon Ltd.
![]() Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Allen Goodship via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Bristol | College/University | Doctorate Degree Doctorate Degree | |
Cranfield University | College/University | Masters Business Admin | |
DegraSense Ltd. | Director/Board Member | ||
HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
hVIVO Services Ltd.
![]() hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Internet Software/Services | Director/Board Member | |
IXICO PLC | Miscellaneous Commercial Services | Director/Board Member | |
HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
Genomics Plc
![]() Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
DEEPMATTER GROUP PLC | Packaged Software | Chief Executive Officer | |
IP GROUP PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ubiquigent Ltd.
![]() Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Iksuda Therapeutics Ltd.
![]() Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
Wyvern Asset Management Ltd.
![]() Wyvern Asset Management Ltd. Investment ManagersFinance Wyvern Asset Management Ltd. (Wyvern Asset Management) is an independent venture capital firm founded in 1999. The firm is headquartered in Bristol, United Kingdom. | Investment Managers | Chief Executive Officer | |
The Royal Society of Chemistry
![]() The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Receptor Research Ltd.
![]() Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Part of Tripos, Inc., Receptor Research Ltd. provides drug discovery informatics products and services. The company is based in Bude, UK. Receptor Research was acquired by Tripos, Inc. on November 18, 1997. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Activiomics Ltd.
![]() Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
The University of Sheffield | College/University | Corporate Officer/Principal | |
McGill University | College/University | Corporate Officer/Principal | |
University of Bath | College/University | Undergraduate Degree | |
Southampton Business School | College/University | Undergraduate Degree | |
Anauel LLP | Corporate Officer/Principal | ||
KWS BioTest Ltd.
![]() KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Angelini Ventures SpA
![]() Angelini Ventures SpA Investment ManagersFinance Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor |
Statistiques
Internationale
Royaume-Uni | 24 |
Etats-Unis | 3 |
Canada | 2 |
Italie | 2 |
Sectorielle
Commercial Services | 8 |
Consumer Services | 7 |
Health Technology | 6 |
Technology Services | 4 |
Finance | 4 |
Opérationnelle
Director/Board Member | 15 |
Corporate Officer/Principal | 8 |
Chief Executive Officer | 3 |
Chairman | 3 |
Undergraduate Degree | 3 |
Relations les plus connectées
Insiders | |
---|---|
Mark Robert Warne | 19 |
Andrew Allars | 7 |
Anthony Hollander | 5 |
Helen Delahaye | 1 |
- Bourse
- Insiders
- Allen Goodship
- Connexions Sociétés